Adenoviral delivery of soluble VEGF receptor 1 (sFlt-1) inhibits experimental autoimmune encephalomyelitis in dark Agouti (DA) rats

Life Sciences

Volumn 83, Issue 11-12, 2008, Pages 404-412

  Zhu, Can Sheng ^a   Hu, Xue Qiang ^a   Xiong, Zhao Jun ^a   Lu, Zheng Qi ^a   Zhou, Guo Yu ^a   Wang, Dun Jing ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Experimental autoimmune encephalomyelitis; Gene therapy; Inflammation; sFlt 1(1 3) gene

Indexed keywords

ADENOVIRUS VECTOR; MATRIGEL; VASCULOTROPIN RECEPTOR 1;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CELL COUNT; CELL INFILTRATION; CONTROLLED STUDY; DISEASE SEVERITY; GENE TRANSFER; GENETIC TRANSFECTION; INFLAMMATORY CELL; MALE; MONOCYTE; NONHUMAN; RAT; RAT STRAIN; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE; ANIMALS; BLOTTING, WESTERN; BRAIN CHEMISTRY; CELL LINE; CELL MOVEMENT; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; GENE THERAPY; GENETIC VECTORS; IMMUNOHISTOCHEMISTRY; KINETICS; MALE; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPINAL CORD; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

AGOUTI; RATTUS;

EID: 50849089973     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2008.07.009     Document Type: Article

References (37)

1. Afuwape A.O., Feldmann M., and Paleolog E.M. Adenoviral delivery of soluble VEGF receptor 1 (sFlt-1) abrogates disease activity in murine collagen-induced arthritis. Gene Therapy 10 23 (2003) 1950-1960
2. Ballara S., Taylor P.C., Reusch P., Marme D., Feldmann M., Maini R.N., and Paleolog E.M. Raised serum vascular endothelial growth factor levels are associated with destructive change in inflammatory arthritis. Arthritis and Rheumatism 44 9 (2001) 2055-2064
3. Barleon B., Sozzani S., Zhou D., Weich H.A., Mantovani A., and Marmé D. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 87 8 (1996) 3336-3343
4. Barleon B., Totzke F., Herzog C., Blanke S., Kremmer E., Siemeister G., Marmé D., and Martiny-Baron G. Mapping of the sites for ligand binding and receptor dimerization at the extracellular domain of the vascular endothelial growth factor receptor FLT-1. The Journal of Biological Chemistry 272 16 (1997) 10382-10388
5. Clauss M., Gerlach M., Gerlach H., Brett J., Wang F., Familletti P.C., Pan Y.C., Olander J.V., Connolly D.T., and Stern D. Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. The Journal of Experimental Medicine 172 6 (1990) 1535-1545
6. Croll S.D., Ransohoff R.M., Cai N., Zhang Q., Martin F.J., Wei T., Kasselman L.J., Kintner J., Murphy A.J., Yancopoulos G.D., and Wiegand S.J. EGF-mediated inflammation precedes angiogenesis in adult brain. Experimental Neurology 187 2 (2004) 388-402
7. De Bandt M., Ben Mahdi M.H., Ollivier V., Grossin M., Dupuis M., Gaudry M., Bohlen P., Lipson K.E., Rice A., Wu Y., Gougerot-Pocidalo M.A., and Pasquier C. Blockade of vascular endothelial growth factor receptor I (VEGF-RI), but not VEGF-RII, suppresses joint destruction in the K/BxN model of rheumatoid arthritis. The Journal of Immunology 171 9 (2003) 4853-4859
8. Detmar M., Brown L.F., Schön M.P., Elicker B.M., Velasco P., Richard L., Fukumura D., Monsky W., Claffey K.P., and Jain R.K. Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. The Journal of Investigative Dermatology 111 1 (1998) 1-6
9. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other diseases. Nature Medicine 1 1 (1995) 27-31
10. Firestein G.S. Invasive fibroblast-like synoviocytes in rheumatoid arthritis: passive responders or transformed aggressors?. Arthritis and Rheumatism 39 11 (1996) 1781-1790
11. Goldman C.K., Kendall R.L., Cabrera G., Soroceanu L., Heike Y., Gillespie G.Y., Siegal G.P., Mao X., Bett A.J., Huckle W.R., Thomas K.A., and Curiel D.T. Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate. Proceedings of the National Academy of Sciences of the United States of America 95 15 (1998) 8795-8800
12. Graumann U., Reynolds R., Steck A.J., and Schaeren-Wiemers N. Molecular changes in normal appearing white matter in multiple sclerosis are characteristic of neuroprotective mechanisms against hypoxic insult. Brain Pathology 13 4 (2003) 554-573
13. Heil M., Clauss M., Suzuki K., Buschmann I.R., Willuweit A., Fischer S., and Schaper W. Vascular endothelial growth factor (VEGF) stimulates monocyte migration through endothelial monolayers via increased integrin expression. European Journal of Cell Biology 79 11 (2000) 850-857
14. Heppner F.L., Greter M., Marino D., Falsig J., Raivich G., Hövelmeyer N., Waisman A., Rülicke T., Prinz M., Priller J., Becher B., and Aguzzi A. Experimental autoimmune encephalomyelitis repressed by microglial paralysis. Nature Medicine 11 2 (2005) 146-152
15. Hickey W.F., Hsu B.L., and Kimura H. T-lymphocyte entry into the central nervous system. Journal of Neuroscience Research 28 2 (1991) 254-260
16. Hitchon C., Wong K., Ma G., Reed J., Lyttle D., and El-Gabalawy H. Hypoxia-induced production of stromal cell-derived factor 1 (CXCL12) and endothelial growth factor by synovial fibroblasts. Arthritis and Rheumatism 46 10 (2002) 2587-2597
17. Iijima K., Yoshikawa N., Connolly D.T., and Nakamura H. Human mesangial cells and peripheral blood mononuclear cells produce vascular permeability factor. Kidney International 44 5 (1993) 959-966
18. Kendall R.L., Wang G., and Thomas K.A. Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR. Biochemical and Biophysical Research Communications 226 2 (1996) 324-328
19. Kim I., Moon S.O., Kim S.H., Kim H.J., Koh Y.S., and Koh G.Y. Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells. The Journal of Biological Chemistry 276 10 (2001) 7614-7620
20. Kirk S.L., and Karlik S.J. VEGF and vascular changes in chronic neuroinflammation. Journal of Autoimmunity 21 4 (2003) 353-363
21. Koch A.E., Harlow L.A., Haines G.K., Amento E.P., Unemori E.N., Wong W.L., Pope R.M., and Ferrara N. Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis. The Journal of Immunology 152 8 (1994) 4149-4156
22. Lai C.M., Brankov M., Zaknich T., Lai Y.K., Shen W.Y., Constable I.J., Kovesdi I., and Rakoczy P.E. Inhibition of angiogenesis by adenovirus-mediated sFlt-1 expression in a rat model of corneal neovascularization. Human Gene Therapy 12 10 (2001) 1299-1310
23. Le Gal La Salle G., Robert J.J., Berrard S., Ridoux V., Stratford-Perricaudet L.D., Perricaudet M., and Mallet J. An adenovirus vector for gene transfer into neurons and glia in the brain. Science 259 5097 (1993) 988-990
24. Lorentzen J.C., Issazadeh S., Storch M., Mustafa M.I., Lassman H., Linington C., Klareskog L., and Olsson T. Protracted, relapsing and demyelinating experimental autoimmune encephalomyelitis in DA rats immunized with syngeneic spinal cord and incomplete Freund's adjuvant. Journal of Neuroimmunology 63 2 (1995) 193-205
25. Lucchinetti C.F., Parisi J., and Bruck W. The pathology of multiple sclerosis. Neurologic Clinics 23 1 (2005) 77-105
26. Luttun A., Tjwa M., Moons L., Wu Y., Angelillo-Scherrer A., Liao F., Nagy J.A., Hooper A., Priller J., De Klerck B., Compernolle V., Daci E., Bohlen P., Dewerchin M., Herbert J.M., Fava R., Matthys P., Carmeliet G., Collen D., Dvorak H.F., Hicklin D.J., and Carmeliet P. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nature Medicine 8 8 (2002) 831-840
27. Mahendra G., Kumar S., Isayeva T., Mahasreshti P.J., Curiel D.T., Stockardt C.R., Grizzle W.E., Alapati V., Singh R., Siegal G.P., Meleth S., and Ponnazhagan S. Antiangiogenic cancer gene therapy by adeno-associated virus 2-mediated stable expression of the soluble FMS-like tyrosine kinase-1 receptor. Cancer Gene Therapy 12 1 (2005) 26-34
28. Marumo T., Schini-Kerth V.B., and Busse R. Vascular endothelial growth factor activates nuclear factor-kappaB and induces monocyte chemoattractant protein-1 in bovine retinal endothelial cells. Diabetes 48 5 (1999) 1131-1137
29. McQualter J.L., Darwiche R., Ewing C., Onuki M., Kay T.W., Hamilton J.A., Reid H.H., and Bernard C.C. Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis. The Journal of Experimental Medicine 194 7 (2001) 873-882
30. Mor F., Quintana F.J., and Cohen I.R. Angiogenesis-inflammation cross-talk: vascular endothelial growth factor is secreted by activated T cells and induces Th1 polarization. The Journal of Immunology 172 7 (2004) 4618-4623
31. Proescholdt M.A., Jacobson S., Tresser N., Oldfield E.H., and Merrill M.J. Vascular endothelial growth factor is expressed in multiple sclerosis plaques and can induce inflammatory lesions in experimental allergic encephalomyelitis rats. Journal of Neuropathology and Experimental Neurology 61 10 (2002) 914-925
32. Proescholdt M.A., Heiss J.D., Walbridge S., Mühlhauser J., Capogrossi M.C., Oldfield E.H., and Merrill M.J. Vascular endothelial growth factor (VEGF) modulates vascular permeability and inflammation in rat brain. Journal of Neuropathology and Experimental Neurology 58 6 (1999) 613-627
33. Reinders M.E., Sho M., Izawa A., Wang P., Mukhopadhyay D., Koss K.E., Geehan C.S., Luster A.D., Sayegh M.H., and Briscoe D.M. Proinflammatory functions of vascular endothelial growth factor in alloimmunity. The Journal of Clinical Investigation 112 11 (2003) 1655-1665
34. Su J.J., Osoegawa M., Matsuoka T., Minohara M., Tanaka M., Ishizu T., Mihara F., Taniwaki T., and Kira J. Upregulation of vascular growth factors in multiple sclerosis: correlation with MRI findings. Journal of the Neurological Sciences 243 1-2 (2006) 21-30
35. Weber A.J., De Bandt M., and Gaudry M. Immunohistochemical analysis of vascular endothelial growth factor expression in severe and destructive rheumatoid arthritis. The Journal of Rheumatology 27 9 (2000) 2284-2286
36. Ye C., Feng C., Wang S., Wang K.Z., Huang N., Liu X., Lin Y., and Li M. sFlt-1 gene therapy of follicular thyroid carcinoma. Endocrinology 145 2 (2004) 817-822
37. Zittermann S.I., and Issekutz A.C. Endothelial growth factors VEGF and bFGF differentially enhance monocyte and neutrophil recruitment to inflammation. Journal of Leukocyte Biology 80 2 (2006) 247-257